Effects of combination treatment of intravesical Resiniferatoxin instillation and hydrodistention in patients with refractory painful bladder syndrome/interstitial Cystitis: A pilot study

International Neurourology Journal

Volumn 16, Issue 1, 2012, Pages 41-46

  Ham, Byeong Kuk ^a   Kim, Jae Heon ^a   Oh, Mi Mi ^a   Lee, Jeong Gu ^a   Bae, Jae Hyun ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Interstitial cystitis; Intravesical administration; Pain; Resiniferatoxin

Indexed keywords

RESINIFERATOXIN;

ADULT; ARTICLE; BLADDER CAPACITY; CONTROLLED STUDY; CYSTALGIA; FEMALE; HUMAN; HYDRODISTENTION; INTERSTITIAL CYSTITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; PAIN ASSESSMENT; PILOT STUDY; POSTVOID RESIDUAL URINE VOLUME; RANDOMIZED CONTROLLED TRIAL (TOPIC); URINE FLOW RATE; UROFLOWMETRY; VISUAL ANALOG SCALE;

EID: 84866918122     PISSN: 20934777     EISSN: 20936931     Source Type: Journal    
DOI: 10.5213/inj.2012.16.1.41     Document Type: Article

References (19)

1. Hanash KA, Pool TL. Interstitial cystitis in men. J Urol 1969;102: 427-8.
2. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988;140:203-6.
3. van De Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008;53:60-7.
4. Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, et al. Bladder Pain Syndrome Committee of the International Consultation on Incontinence. Neurourol Urodyn 2010;29:191-8.
5. Cole EE, Scarpero HM, Dmochowski RR. Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodistention? Neurourol Urodyn 2005;24:638-42.
6. Theoharides TC. Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs 2007;67:215-35.
7. Kusek JW, Nyberg LM. The epidemiology of interstitial cystitis: is it time to expand our definition? Urology 2001;57(6 Suppl 1):95-9.
8. Nickel JC, Tripp DA, Pontari M, Moldwin R, Mayer R, Carr LK, et al. Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study. J Urol 2010;183: 167-72.
9. Franksson C. Interstitial cystitis: a clinical study of fifty-nine cases. Acta Chir Scand 1957;113:51-62.
10. Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology 2005;66:494-9.
11. Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 2011;185:2162-70.
12. Lazzeri M, Beneforti P, Benaim G, Maggi CA, Lecci A, Turini D. Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study. J Urol 1996;156:947-52.
13. Apostolidis A, Gonzales GE, Fowler CJ. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol 2006;50:1299-305.
14. Lazzeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D. Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 2000;164(3 Pt 1):676-9.
15. Chen TY, Corcos J, Camel M, Ponsot Y, Tule M. Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int Urogynecol J Pelvic Floor Dysfunct 2005;16:293-7.
16. Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 2005;173:1590-4.
17. Silva C, Ribeiro MJ, Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 2002;168:575-9.
18. Rios LA, Panhoca R, Mattos D Jr, Srugi M, Bruschini H. Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: a single dose, 4 weeks, double-blind, randomized, placebo controlled trial. Neurourol Urodyn 2007;26:773-8.
19. Peng CH, Kuo HC. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis. Urol Int 2007;78:78-81.